October 10, 2012 (London, United Kingdom) — New data--including results from registries in Latin America, Asia, and parts of Europe--suggest that rates of pacemaker implantation following ...

Medical device major Medtronic plc’s MDT renowned transcatheter aortic valve replacement (TAVI) system – the CoreValve – has recently received Japanese regulatory approval for implantation in patients ...

The approval is based on the positive results depicted by the High Risk study of the CoreValve U.S. Pivotal Trial, where the CoreValve System has shown superior clinical outcomes compared to ...

Please provide your email address to receive an email when new articles are posted on . Medtronic announced that the FDA has approved its self-expanding transcatheter CoreValve System for patients ...